DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Anaheim Marriott

2023年4月17日 (月) 午前 7:00 - 2023年4月19日 (水) 午後 6:30

700 West Convention Way, Anaheim, CA 92802

Medical Affairs and Scientific Communications Forum

Session 6 Track 1: Considerations Pertaining to Medical-commercial Collaborations Including PRC and MRC

Session Chair(s)

Darshan  Kulkarni, JD, PharmD, MS

Darshan Kulkarni, JD, PharmD, MS

Principal Attorney

The Kulkarni Law Firm, United States

This session will discuss the importance of cross-functional collaboration between medical communication and advertising and promotion functional areas within an organization. This session will provide an overview of the overall training and auditing needed for promotional review committees (PRC), medical, legal, and regulatory (MLR) review, or MRC review to ensure compliance of external and internal regulations and guidelines for the marketing and promotion of materials for one’s company and organization. We will consider not only US but also Canadian considerations.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify essential training opportunities for PRC Committees
  • Appraise auditing processes available to review PRC Committee processes
  • List regulations and guidelines that are essential and relevant for promotional materials

Speaker(s)

Randy  Levitt, PhD

Speaker

Randy Levitt, PhD

Paladin Labs Inc., Canada

Director, Pharmacovigilance and Medical Affairs

Allyson  Chambers

Speaker

Allyson Chambers

Alkermes, United States

Director, Regulatory Affairs Advertising & Promotion

Payal  Desai, PharmD

Speaker

Payal Desai, PharmD

Janssen Scientific Affairs, LLC., United States

Associate Director, Integrated Evidence Team Lead

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。